Gapping up
In reaction to earnings/guidance:
- KFY +6.7%, COUP +5.2%, AGX +3.9%, PTVE +3.8%, VAPO +1.6%, JCI +1.1%
Other news:
- KDMN +73.6% (to be acquired by Sanofi (SNY) for $9.50 per share)
- IFRX +22.7% (plans to proceed with a pivotal development program for vilobelimab in Hidradenitis Suppurativa after a successful Type A meeting with the FDA)
- ADMA +11.4% (receives FDA approval for VanRx aseptic fill-finish machine and related operations)
- PTVE +3.8% (to acquire Fabri-Kal)
- NNDM +3% (announces collaboration with Fraunhofer Institute to develop 3D printing systems)
- ASPS +2.9% (considering potential sale of its origination business, according to Bloomberg)
- TBPH +2.4% (Point72 Asset Mgmt discloses 7.0% stake)
- GRTX +2.4% (reports final results from pancreatic cancer trial)
- FUN +2.2% (reports continuation of strong attendance and guest spending trends through Labor Day weekend)
- JMP +1.8% (Citizens Financial Group (CFG) to acquire JMP Group LLC for $7.50/share)
- PRGO +1.7% (to acquire Héra SAS)
- LYB +1.7% (weighing strategic options for refining business)
- LHCG +1.3% (to purchase Brookdale Health Care Services agencies from the recently formed home health, hospice and outpatient therapy venture between HCA Healthcare and Brookdale Senior Living (BKD))
- IGT +1.3% (established a dedicated Digital & Betting business segment)
- WMB +1% (authorized a share repurchase program for the repurchase of up to $1.5 bln of the company's outstanding common stock)
Analyst comments:
- SBOW +5.6% (upgraded to Buy from Hold at Truist)
- OLLI +3.7% (upgraded to Buy from Hold at Berenberg)
- NGD +2.4% (upgraded to Sector Perform from Underperform at RBC Capital Mkts)
- ALB +1.8% (upgraded to Buy from Sell at Berenberg)